Filtered By:
Specialty: Urology & Nephrology
Therapy: Radiation Therapy

This page shows you your search results in order of date.

Order by Relevance | Date

Total 299 results found since Jan 2013.

LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients
CONCLUSIONS: Subclassification of IR prostate cancer into FIR and UIR subcategories appears mandatory. For FIR patients, outcomes after BT monotherapy were acceptable. However, clinical failure after 125J-LDR-BT in UIR patients was notably increased, suggesting that BT monotherapy was less successful in this risk group. In contrast, the outcome in UIR patients after CRT was excellent.PMID:37714724 | DOI:10.1016/j.urolonc.2023.08.007
Source: Urologic Oncology - September 15, 2023 Category: Urology & Nephrology Authors: Andreas Boehle Dorothea Zywietz Irina Robrahn-Nitschke Achim Lusch Inke R K önig Source Type: research

Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer
CONCLUSIONS: RT after RP was associated with an increase in the risk of cystitis and worse general health in the long term. Other complications and HRQOL outcomes did not demonstrate differences by whether patients had RT or not. While post-operative RT is the only curative option for CaP after RP, patients and providers should be aware of the increased risks when making treatment decisions.PMID:37407420 | DOI:10.1016/j.urolonc.2023.06.003
Source: Urologic Oncology - July 5, 2023 Category: Urology & Nephrology Authors: Avi Baskin Janet E Cowan Avery Braun Peter E Lonergan Osama Mohamad Samuel L Washington Shoujun Zhao Jeanette M Broering Matthew R Cooperberg Benjamin N Breyer Peter R Carroll Source Type: research

Wilms Tumor
Urol Clin North Am. 2023 Aug;50(3):455-464. doi: 10.1016/j.ucl.2023.04.008. Epub 2023 May 18.ABSTRACTWilms tumor (WT), or nephroblastoma, is the most common primary malignant renal tumor of childhood. It is an embryonal tumor that develops from remnants of immature kidney. There are approximately 500 new WT cases diagnosed in the United States every year. Advances in multimodal therapy including surgery, chemotherapy, and radiation therapy given according to risk stratification have allowed most patients to achieve survival rates in excess of 90%.PMID:37385707 | DOI:10.1016/j.ucl.2023.04.008
Source: The Urologic Clinics of North America - June 29, 2023 Category: Urology & Nephrology Authors: Amanda F Saltzman Nicholas G Cost Rodrigo L P Romao Source Type: research